• Absoludy Beta-Amyloid is PIFA Technology(Photooxidation induced Fluorescence Amplification) based quantitative measuring diagnostic test.

• Measuring the level of Beta-Amyloid to diagnose Alzheimer disease. The global Alzheimer's Disease (AD) market, worth $2.9 billion in 2016, is predicted to reach $14.8 billion by 2026 across US, Japan, France, Germany, Italy, Spain, and the UK (the seven major markets), according to business information and analytics company Global Data. This shows an annual growth rate of 17.5%. [By Pharmaceutical Executive Editors]